# Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3

> **NCT00565396** · NA · UNKNOWN · sponsor: **Shanghai Municipal Health Bureau** · enrollment: 400 (estimated)

## Conditions studied

- Chronic Kidney Insufficiency
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin II Type 1 Receptor Blockers
- Proteinuria

## Interventions

- **DRUG:** Fosinopril and Losartan

## Key facts

- **NCT ID:** NCT00565396
- **Lead sponsor:** Shanghai Municipal Health Bureau
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2008-07
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2007-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565396, "Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00565396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*